Company intelligence / Profile preview

CaverStem International

Phoenix, Arizona, United States

Ownership: Private
Development stage: Other

Overview

The CaverStem procedure uses autologous bone marrow-derived stem cells injected into penile tissue to regenerate blood vessels and smooth muscle in men with erectile dysfunction; several hundred patients treated, significant success rates, and no serious adverse effects reported, with recovery of erection duration and frequency noted within three months post-procedure

Therapeutic areas: Men's Health
Modalities: Stem cell therapyCell therapy
Industry: Biotech

Partnerships

Edge Media Network (marketing)partnerships with clinical centers for provider training

Beyond the preview

Go deeper on CaverStem International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CaverStem International.

Explore the full profile